MedImmune Submits Marketing Authorisation Application in European Union for...
Nijmegen, The Netherlands (ots/PRNewswire) – MedImmune, the global biologics unit of AstraZeneca, announced today that it has submitted a Marketing Authorisation Application (MAA) for its nasal spray...
View ArticleRelease of a Corporate News, transmitted by DGAP – a company of EquityStory AG
(pressebox) Planegg-Martinsried, 04.03.2009, The Martinsried-based drug discovery and development company 4SC AG (Frankfurt, Prime Standard: VSC) today announced the start of a phase IIa clinical trial...
View ArticleWith New National Immunisation Programme in Saudi Arabia, Thirty-Five...
Maidenhead, England (ots/PRNewswire) – – Prevenar Helps Protect Children Against the Leading Vaccine-Preventable Cause of Death in Children Younger than Five Years of Age Worldwide Wyeth today...
View ArticleWyeth Submits Marketing Application to FDA for its 13-Valent Vaccine for the...
Collegeville, Pennsylvania (ots/PRNewswire) – – Candidate vaccine designed to protect against the 13 most prevalent serotypes associated with pneumococcal disease – Wyeth Pharmaceuticals, a division of...
View ArticleNew Study Shows Nplate(R) Significantly Reduces Splenectomy Rate and...
Berlin (ots/PRNewswire) – Amgen Inc. (Nasdaq: AMGN) today released the results of a new study comparing Nplate(R) (romiplostim) to the medical standard of care (SOC) in non-splenectomised adult...
View ArticleWyeth Receives Positive Opinion from European Regulators for its 13-valent...
Collegeville, Pennsylvania (ots/PRNewswire) – Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that the European Medicines Agency’s (EMEA) Committee for Medicinal Products for...
View ArticleInternational Society for Cellular Therapy (ISCT) Launches Inaugural Cell...
Vancouver (ots/PRNewswire) – In keeping with its commitment to connect industry, regulatory experts, therapeutic societies and translational centers to advance emerging cellular therapies, ISCT...
View ArticleEANS-Adhoc: Intercell announces next steps of development for Pseudomonas...
——————————————————————————– ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement....
View ArticleEANS-News: SYGNIS Pharma AG / SYGNIS strengthens its KIBRA-Project: first...
——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Patents, Copyright...
View ArticleShire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator...
Dublin (ots/PRNewswire) – ? Shire plc , the global specialty biopharmaceutical company, announces that it has signed an agreement to acquire FerroKin BioSciences, Inc., for an upfront payment of $100...
View ArticleEisai Disagrees with German Institute for Quality and Efficiency in Health...
Hatfield, England (ots/PRNewswire) – In the assessment report by the Institute for Quality and Efficiency in Health Care (IQWiG) on Fycompa(R) (perampanel), published today on the Federal Joint...
View Article
